Lexicon Pharmaceuticals (LXRX) Inventory Average (2017 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Inventory Average of $278500.0 for Q1 2026, up 28.94% year-over-year from $216000.0 in Q1 2025, and up 26.88% quarter-over-quarter from $219500.0 in Q4 2025.
Powered by 
Analysis
Lexicon Pharmaceuticals (LXRX) Inventory Average (2017 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Inventory Average for 8 consecutive years, with $278500.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 28.94% year-over-year to $278500.0; the TTM figure through Mar 2026 stood at $278500.0 (up 28.94% YoY), while the FY2025 annual figure was $256000.0, down 16.34% from the prior year.
- Inventory Average grew to $278500.0 in Q1 2026 per LXRX's latest filing, from $219500.0 in the prior quarter.
- Across five years, Inventory Average topped out at $610500.0 in Q3 2024 and bottomed at $163000.0 in Q3 2025.
- Historically, Inventory Average has averaged $337727.3 across 4 years, with a median of $278500.0 in 2026.
- Annual changes were most pronounced in 2024 — Inventory Average surged 140.35% — and 2025, when it sank 73.3%.
- Lexicon Pharmaceuticals' Inventory Average stood at $358500.0 in 2023, then advanced by 20.92% to $433500.0 in 2024, then sank by 49.37% to $219500.0 in 2025, then grew by 26.88% to $278500.0 in 2026.
- Business Quant data shows LXRX's Inventory Average at $278500.0 in Q1 2026, $219500.0 in Q4 2025, and $163000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 213.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 707.10 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Lexicon Pharmaceuticals | 978.15 Mn | 787.54 Mn | 653,000.00 | 736,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 736,000.00 |
| Mar 31, 2026 | 278,500.00 |
| Dec 31, 2025 | 219,500.00 |
| Sep 30, 2025 | 163,000.00 |
| Jun 30, 2025 | 184,500.00 |
| Mar 31, 2025 | 216,000.00 |
| Dec 31, 2024 | 433,500.00 |
| Sep 30, 2024 | 610,500.00 |
| Jun 30, 2024 | 549,500.00 |
| Mar 31, 2024 | 447,500.00 |
| Dec 31, 2023 | 358,500.00 |
| Sep 30, 2023 | 254,000.00 |
| Jun 30, 2020 | 4.07 Mn |
| Mar 31, 2020 | 4.20 Mn |
| Dec 31, 2019 | 4.36 Mn |
| Sep 30, 2019 | 4.38 Mn |
| Jun 30, 2019 | 4.44 Mn |
| Mar 31, 2019 | 4.64 Mn |
| Dec 31, 2018 | 4.72 Mn |
| Sep 30, 2018 | 3.45 Mn |